Changes in nasal and throat microbiota composition during and after mupirocin and chlorhexidine decolonisation treatment in asymptomatic MRSA carriers: a longitudinal observational study
Clinical Microbiology and Infection · 2026
DOI: 10.1016/j.cmi.2026.02.020 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Microbiology and Infection, 2026. Verfasst von Sofie Marie Edslev und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark; European Society of Clinical Microbiology and Infectious Di…. Hauptthemen laut MEDLINE: Mupirocin, Chlorhexidine, Methicillin-Resistant Staphylococcus aureus, Carrier State. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
OBJECTIVES: Decolonization treatment of asymptomatic methicillin-resistant Staphylococcus aureus (MRSA) carriage is recommended as a preventive measure in several countries, including Denmark. This study aimed to investigate the temporal dynamics of the nasal and throat microbiota in MRSA carriers undergoing decolonization treatment and to assess bacterial changes associated with treatment success. METHODS: Adults with asymptomatic nasal MRSA carriage (n = 34) were included in this prospective observational study. Participants underwent a 5-day decolonization regimen consisting of 2% mupirocin nasal ointment and daily skin cleansing with 4% chlorhexidine soap. Nasal and throat samples were collected at multiple time points from baseline to 6 months after treatment and analysed by 16S rRNA gene sequencing. A reference group of untreated community-dwelling adults (n = 116) served as comparison. RESULTS: At 1-month follow-up, 21 of 34 participants (62%) were successfully decolonized, whereas 13 (38%) remained MRSA positive at one or more body sites. At baseline, no nasal bacterial taxa were significantly associated with nasal MRSA decolonization outcome. The nasal bacterial community changed significantly within the first 2 days of treatment and remained distinct from the baseline composition for 30 days, both among those with successful decolonization and those who remained colonized with MRSA. Nasal community state types characterized by S. aureus, coagulase-negative staphylococci, Moraxella, and Dolosigranulum became less prevalent during treatment, whereas community state types dominated by Corynebacterium and Cutibacterium increased in prevalence. Among successfully decolonized participants, the nasal microbiota at 3 and 6 months after treatment continued to differ from baseline and from the reference group, mainly because of a sustained depletion of Dolosigranulum and Moraxella. In contrast, the throat microbiota showed only short-term compositional changes. CONCLUSIONS: Decolonization treatment significantly alters the nasal microbiota, with both short-term and persistent effects. Future strategies could consider supplementation with beneficial nasal commensals, such as Dolosigranulum, after treatment to promote microbiome recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Staphylococci and Staphylococcal Disea…
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Staphylococci and Staphylococcal Diseases (ESGS), Basel, Switzerland; Antibiotic Resistance Action Center, Department of Environ…
- Department of Clinical Microbiology and MRSA Knowledge Center, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.
- Department of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.
- Antibiotic Resistance Action Center, Department of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Staphylococci and Staphylococcal Diseases (ESGS), Basel, Switzerland; Department of Clinical Microbiology and MRSA Knowledge Cen…
Förderung
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Edslev, S. M., Liu, C. M., Sheng Lo, B. Z., Meiniche, H., Lilje, B., Park, D. E., Rendboe, A., Pham, T., Salazar, J. E., Toudahl, T., Ingham, A. C., Aziz, M., Bartels, M. D., Andersen, P. S., Skov, R. L., Price, L. B., & Stegger, M. (2026). Changes in nasal and throat microbiota composition during and after mupirocin and chlorhexidine decolonisation treatment in asymptomatic MRSA carriers: a longitudinal observational study. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2026.02.020
Vancouver
Edslev SM, Liu CM, Sheng Lo BZ, Meiniche H, Lilje B, Park DE, et al. Changes in nasal and throat microbiota composition during and after mupirocin and chlorhexidine decolonisation treatment in asymptomatic MRSA carriers: a longitudinal observational study. Clinical Microbiology and Infection. 2026. doi:10.1016/j.cmi.2026.02.020
BibTeX
@article{Edslev2026,
author = {Edslev, Sofie Marie and Liu, Cindy M and Sheng Lo, Bobby Zhao and Meiniche, Heidi and Lilje, Berit and Park, Daniel E and Rendboe, Amalie and Pham, Tony and Salazar, Juan E and Toudahl, Tor and Ingham, Anna Cäcilia and Aziz, Maliha and Bartels, Mette Damkjær and Andersen, Paal Skytt and Skov, Robert Leo and Price, Lance B and Stegger, Marc},
title = {Changes in nasal and throat microbiota composition during and after mupirocin and chlorhexidine decolonisation treatment in asymptomatic MRSA carriers: a longitudinal observational study},
journal = {Clinical Microbiology and Infection},
year = {2026},
doi = {10.1016/j.cmi.2026.02.020}
}
EUVIMED